To amend title XI of the Social Security Act to alter when biosimilar biological products are eligible for price negotiations under the Medicare program. HR 10628
To prohibit the obligation or expenditure of Department of Health and Human Services funds for the use of live dogs and live cats in biomedical research, to strengthen accountability for Federal research expenditures, and for other purposes. HR 10522